Comparative analysis of the total brain samples resulted in the identification of five genes (CANX, DNAJC5, MGEA5, TMEM66, WDR92) with statistically significant usage of alternative promoters in AD samples (p<0.05 and passing false discovery rate threshold). This evidence concerns the gene OGA and Alzheimer disease.